Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial

Thirty years after its discovery, the hepatitis C virus (HCV) remains a leading cause of liver disease worldwide. Given that many countries continue to experience high rates of transmission despite the availability of potent antiviral therapies, an effective vaccine is seen as critical for the elimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelps, Christopher C., Walker, Christopher M., Honegger, Jonathan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310243/
https://www.ncbi.nlm.nih.gov/pubmed/34372558
http://dx.doi.org/10.3390/v13071351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310243/
https://www.ncbi.nlm.nih.gov/pubmed/34372558
http://dx.doi.org/10.3390/v13071351

Ejemplares similares